Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
948.3 INR | -0.88% |
|
+0.70% | +46.06% |
23/05 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
22/05 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.06% | 105.43Cr | |
+16.80% | 4.33TCr | |
+17.47% | 2.16TCr | |
+21.62% | 1.59TCr | |
+23.95% | 1.51TCr | |
+57.96% | 1.3TCr | |
-0.05% | 678.76Cr | |
-16.22% | 629.03Cr | |
+19.77% | 603.62Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3%